Phillips T, Wang M, Robak T, Gallinson D, Stevens D, Patel K, Ramadan S, Wun C-C, Jurczak W, Smith SD. Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naïve or relapsed/refractory mantle cell lymphoma: phase Ib trial. Haematologica 2025;110(3):715-724; https://doi.org/10.3324/haematol.2023.284896.